Family Medicine Doctors in Panguitch, UT Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Dr. Todd Stanley Mooney, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 E 200 N, Panguitch, UT 84759 Phone: 435-676-8811 Fax: 435-676-2679 |
Dr. Richard Glen Birch, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 N 400 E, Panguitch, UT 84759 Phone: 435-676-8811 Fax: 435-676-2679 |
Colin Thomas Marshall, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 N 400 E, Panguitch, UT 84759 Phone: 435-676-2252 Fax: 435-676-1544 |
 Melinda Lee Peterson, APRN Family Medicine Medicare: Medicare Enrolled Practice Location: 200 N 400 E, Panguitch, UT 84759 Phone: 435-676-8842 |
News Archive
Medidata Solutions second quarter net revenues increase 25% to $50.2 million
Medidata Solutions, a leading global provider of SaaS-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the second quarter 2011, as well as provided financial guidance for the third quarter and full year 2011.
New study shows that bypass surgery is more successful than stents in heart surgery
A study of nearly 60,000 patients has found that people with several clogged heart arteries did better if they had bypass surgery rather than a less-drastic procedure in which the blood vessels are propped open with tiny mesh cylinders called stents.
Simple steps can improve malaria prevention
Megan Fotheringham, a public health adviser with the President's Malaria Initiative, describes in a post on USAID's "IMPACTblog" how a program in Kenya worked to improve the successful administration of malaria prevention therapy among pregnant women in the country's Gem District simply by sending to antenatal clinics a memo describing when to administer the treatment.
Neuroscientist to discuss teenage brain development at AAAS meeting in California
Teenage exploration and risk taking could be explained by dramatic changes in the brain that allow elaborate planning and are driven by the need for immediate reward, according to a University of Pittsburgh neuroscientist who will be talking about her research in a panel discussion and press briefing at the American Association for the Advancement of Science annual meeting, Feb. 13 to 16, in San Jose, Calif.
Neuralstem files IND with FDA for spinal cord stem cell Phase I clinical trial for chronic spinal cord injury
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin a Phase I safety clinical trial for chronic spinal cord injury with its spinal cord stem cells. This multicenter Phase I safety trial will enroll a total of 16 long-term, or chronic, spinal cord injury patients, with an American Spinal Injury Association (ASIA) Grade A level of impairment, one-to-two years post-injury.
› Verified 5 days ago